Author： Ubbink J.B.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.13, Iss.6, 1998-12, pp. : 415-420
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Who Should Receive HMG CoA Reductase Inhibitors?
By Teo K.K.
Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. :
Access to resources
Recommend
Who should receive booster hepatitis B vaccinations?
Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. :
Should patients with severe sepsis receive drotrecogin alfa?
Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. :
Should Pediatric Patients with Hyperlipidemia Receive Drug Therapy?
By Bhatnagar D.
Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. :